Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Maximising R+D efforts through better epidemiology understanding

Maximising R+D efforts through better epidemiology understanding

FromConversations in Healthcare


Maximising R+D efforts through better epidemiology understanding

FromConversations in Healthcare

ratings:
Length:
23 minutes
Released:
Nov 18, 2020
Format:
Podcast episode

Description

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Mike Hughes, Senior Director of Epidemiology at DRG. With epidemiology entering our daily vernacular, thanks to the Covid-19 pandemic, Mike gives a definition of what it is, the approaches used to model epidemiology associated with diseases and how it’s beneficial across all stages of research and development in pharma. In particular, they talk about the value epidemiology can bring to decision making and how it can aid in maximizing R&D efforts and investment decisions surrounding pipeline development and go to market plans. Hosted on Acast. See acast.com/privacy for more information.
Released:
Nov 18, 2020
Format:
Podcast episode

Titles in the series (48)

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.   Hosted on Acast. See acast.com/privacy for more information.